Hyperhemolysis in a patient with sickle cell disease and recent SARS‐CoV‐2 infection, with complex auto‐ and alloantibody work‐up, successfully treated with tocilizumab-论文-万方医学网

Hyperhemolysis in a patient with sickle cell disease and recent SARS‐CoV‐2 infection, with complex auto‐ and alloantibody work‐up, successfully treated with tocilizumab

导出原文传递

翻译打印收藏纠错

作者： Christine Fuja ^[1] ; Vishesh Kothary ^[2] ; Timothy Clifford Carll ^[3] ; Savita Singh ; Paul Mansfield ; Geoffrey D. Wool

作者单位： Department of Pathology,University of Chicago ^[1] Department of Medicine, Section of Hematology/Oncology,University of Chicago ^[2] American Red Cross, National Reference Laboratory for Blood Group Serology ^[3]

关键词 AIHA/drug‐induced IHA immunohematology (RBC serology blood groups)transfusion complications—non‐infectious

发布时间 2022-09-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Hyperhemolysis in a patient with sickle cell disease and recent SARS‐CoV‐2 infection, with complex auto‐ and alloantibody work‐up, successfully treated with tocilizumab

相似文献

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Hyperhemolysis in a patient with sickle cell disease and recent SARS‐CoV‐2 infection, with complex auto‐ and alloantibody work‐up, successfully treated with tocilizumab

相似文献

相关期刊

检索历史清除